The deletion variant of α2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment.
about
Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?Mild Cognitive Impairment: A Brief Review and Suggested Clinical Algorithm.Genome research in pre-dementia stages of Alzheimer's disease.ADRA2B genotype differentially modulates stress-induced neural activity in the amygdala and hippocampus during emotional memory retrieval.Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review
P2860
The deletion variant of α2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The deletion variant of α2b-ad ...... and mild cognitive impairment.
@en
The deletion variant of α2b-ad ...... and mild cognitive impairment.
@nl
type
label
The deletion variant of α2b-ad ...... and mild cognitive impairment.
@en
The deletion variant of α2b-ad ...... and mild cognitive impairment.
@nl
prefLabel
The deletion variant of α2b-ad ...... and mild cognitive impairment.
@en
The deletion variant of α2b-ad ...... and mild cognitive impairment.
@nl
P2093
P1476
The deletion variant of α2b-ad ...... and mild cognitive impairment.
@en
P2093
Antonia Germanou
Despina Liapi
Eleni Nikolakaki
Makrina Daniilidou
Maria Koutroumani
Thomas Giannakouros
P356
10.1016/J.JNS.2013.02.003
P577
2013-03-15T00:00:00Z